Bottom-Up vs. Top-Down: Inside the US and Chinese Innovation Systems with Chenjian Li | China Considered | Hoover Institution
Host Dr. Elizabeth Economy interviews Dr. Chenjian Li, discussing the fundamental differences between the Chinese and US systems. He highlights China's rapid progress in biotech and pharmaceutical development, predicting the country may produce its first truly innovative drug within five years. While the U.S. excels at "zero-to-one" grassroots innovation stemming from decades of basic research, China has traditionally focused on "one-to-100" government-supported scaling and is now increasingly investing in breakthrough innovation. The conversation concludes with Dr. Li's recommendations for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.